• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

视神经脊髓炎谱系疾病中长链非编码 RNA 的显著上调。

Significant up-regulation of lncRNAs in neuromyelitis optica spectrum disorder.

机构信息

Institute of Human Genetics, Jena University Hospital, Jena, Germany.

Urology and Nephrology Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

出版信息

Sci Rep. 2023 Oct 31;13(1):18692. doi: 10.1038/s41598-023-45457-w.

DOI:10.1038/s41598-023-45457-w
PMID:37907501
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10618193/
Abstract

Neuromyelitis optica spectrum disorder (NMOSD) is an immune-related demyelinating defect. Long non-coding RNAs (lncRNAs) might influence the pathobiology and progression of NMOSD. The current study assessed expression level of NEAT1, PANDAR, MEG3 and TUG1 lncRNAs in the peripheral blood of NMOSD patients compared with healthy individuals. All mentioned lncRNAs were shown to be over-expressed in total NMOSD cases, male NMOSD cases and female NMOSD cases compared with the matching control subgroups. MEG3 had the most robust over-expression in patients subgroups compared with normal subjects. There was no noteworthy difference in the expression of any of lncRNAs between female and male patients. MEG3 had an ideal performance in the differentiation of NMOSD cases from healthy persons (Sensitivity and specificity values = 100%). Other lncRNAs could also efficiently separate NMOSD cases from control subjects (AUC values = 0.97, 0.89 and 0.88 for PANDAR, NEAT1 and TUG1, respectively). Cumulatively, NEAT1, PANDAR, MEG3 and TUG1 lncRNAs can be considered as appropriate disease markers for NMOSD.

摘要

视神经脊髓炎谱系疾病(NMOSD)是一种与免疫相关的脱髓鞘疾病。长链非编码 RNA(lncRNA)可能影响 NMOSD 的病理生物学和进展。本研究评估了 NMOSD 患者与健康个体外周血中 NEAT1、PANDAR、MEG3 和 TUG1 lncRNA 的表达水平。与匹配的对照组相比,所有提到的 lncRNA 在总 NMOSD 病例、男性 NMOSD 病例和女性 NMOSD 病例中均呈过度表达。与正常受试者相比,MEG3 在患者亚组中的表达最为显著。lncRNA 在男性和女性患者之间的表达没有显著差异。MEG3 在区分 NMOSD 病例和健康人方面表现出色(敏感性和特异性值=100%)。其他 lncRNA 也能有效地将 NMOSD 病例与对照组区分开来(AUC 值分别为 PANDAR、NEAT1 和 TUG1 的 0.97、0.89 和 0.88)。总之,NEAT1、PANDAR、MEG3 和 TUG1 lncRNA 可作为 NMOSD 的合适疾病标志物。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b232/10618193/ddde8b198005/41598_2023_45457_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b232/10618193/439cad93d0fb/41598_2023_45457_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b232/10618193/855fb64cb685/41598_2023_45457_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b232/10618193/ddde8b198005/41598_2023_45457_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b232/10618193/439cad93d0fb/41598_2023_45457_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b232/10618193/855fb64cb685/41598_2023_45457_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b232/10618193/ddde8b198005/41598_2023_45457_Fig3_HTML.jpg

相似文献

1
Significant up-regulation of lncRNAs in neuromyelitis optica spectrum disorder.视神经脊髓炎谱系疾病中长链非编码 RNA 的显著上调。
Sci Rep. 2023 Oct 31;13(1):18692. doi: 10.1038/s41598-023-45457-w.
2
Altered non-coding RNA profiles and potential disease marker identification in peripheral blood mononuclear cells of patients with NMOSD.NMOSD 患者外周血单个核细胞中非编码 RNA 谱的改变及潜在疾病标志物的鉴定。
Int Immunopharmacol. 2022 Aug;109:108899. doi: 10.1016/j.intimp.2022.108899. Epub 2022 Jun 9.
3
Expression analysis of Treg-related lncRNAs in neuromyelitis optica spectrum disorder.视神经脊髓炎谱系疾病中 Treg 相关 lncRNAs 的表达分析。
Mult Scler Relat Disord. 2024 Jan;81:105350. doi: 10.1016/j.msard.2023.105350. Epub 2023 Dec 6.
4
Downregulation of lncRNA XIST may promote Th17 differentiation through KDM6A-TSAd pathway in neuromyelitis optica spectrum disorders.长链非编码 RNA XIST 的下调可能通过 KDM6A-TSAd 通路促进视神经脊髓炎谱系疾病中的 Th17 分化。
Mult Scler Relat Disord. 2023 Aug;76:104801. doi: 10.1016/j.msard.2023.104801. Epub 2023 Jun 10.
5
Over-Expression of Immune-Related lncRNAs in Inflammatory Demyelinating Polyradiculoneuropathies.免疫相关长链非编码 RNA 在炎症性脱髓鞘性多发性神经病中的过度表达。
J Mol Neurosci. 2021 May;71(5):991-998. doi: 10.1007/s12031-020-01721-6. Epub 2020 Oct 15.
6
Next-generation sequencing identifies altered whole blood microRNAs in neuromyelitis optica spectrum disorder which may permit discrimination from multiple sclerosis.下一代测序技术鉴定出视神经脊髓炎谱系障碍患者全血中发生改变的微小RNA,这可能有助于与多发性硬化症进行鉴别。
J Neuroinflammation. 2015 Oct 31;12:196. doi: 10.1186/s12974-015-0418-1.
7
Decreased mRNA Expressions of CD40L in Patients with Neuromyelitis Optica Spectrum Disorder.视神经脊髓炎谱系疾病患者中 CD40L 的 mRNA 表达降低。
J Mol Neurosci. 2020 Apr;70(4):610-617. doi: 10.1007/s12031-019-01467-w. Epub 2020 Jan 10.
8
Peripheral expression of long non-coding RNAs in bipolar patients.双相障碍患者外周长链非编码 RNA 的表达。
J Affect Disord. 2019 Apr 15;249:169-174. doi: 10.1016/j.jad.2019.02.034. Epub 2019 Feb 11.
9
Clinical characteristics of late-onset neuromyelitis optica spectrum disorder: A multicenter retrospective study in Korea.韩国多中心回顾性研究:晚发性视神经脊髓炎谱系疾病的临床特征。
Mult Scler. 2017 Nov;23(13):1748-1756. doi: 10.1177/1352458516685416. Epub 2017 Jan 6.
10
Clinical and radiological profile of neuromyelitis optica spectrum disorders in a Pakistani cohort.巴基斯坦队列中视神经脊髓炎谱系疾病的临床和影像学特征。
Mult Scler Relat Disord. 2023 Jun;74:104656. doi: 10.1016/j.msard.2023.104656. Epub 2023 Mar 24.

本文引用的文献

1
Downregulation of lncRNA XIST may promote Th17 differentiation through KDM6A-TSAd pathway in neuromyelitis optica spectrum disorders.长链非编码 RNA XIST 的下调可能通过 KDM6A-TSAd 通路促进视神经脊髓炎谱系疾病中的 Th17 分化。
Mult Scler Relat Disord. 2023 Aug;76:104801. doi: 10.1016/j.msard.2023.104801. Epub 2023 Jun 10.
2
Central nervous system demyelinating diseases: glial cells at the hub of pathology.中枢神经系统脱髓鞘疾病:胶质细胞在病理学中的核心地位。
Front Immunol. 2023 May 16;14:1135540. doi: 10.3389/fimmu.2023.1135540. eCollection 2023.
3
Establishment of a comprehensive diagnostic model for neuromyelitis optica spectrum disorders based on the analysis of laboratory indicators and clinical data.
基于实验室指标和临床数据分析建立视神经脊髓炎谱系疾病综合诊断模型。
Neurol Sci. 2023 Oct;44(10):3647-3657. doi: 10.1007/s10072-023-06853-2. Epub 2023 May 16.
4
TREM2 deficiency inhibits microglial activation and aggravates demyelinating injury in neuromyelitis optica spectrum disorder.TREM2 缺乏抑制小胶质细胞活化并加重视神经脊髓炎谱系疾病的脱髓鞘损伤。
J Neuroinflammation. 2023 Apr 3;20(1):89. doi: 10.1186/s12974-023-02772-3.
5
Non-infectious meningitis and CNS demyelinating diseases: A conceptual review.非感染性脑膜炎和中枢神经系统脱髓鞘疾病:概念性综述。
Rev Neurol (Paris). 2023 Jun;179(6):533-547. doi: 10.1016/j.neurol.2022.10.006. Epub 2023 Feb 11.
6
Altered non-coding RNA profiles and potential disease marker identification in peripheral blood mononuclear cells of patients with NMOSD.NMOSD 患者外周血单个核细胞中非编码 RNA 谱的改变及潜在疾病标志物的鉴定。
Int Immunopharmacol. 2022 Aug;109:108899. doi: 10.1016/j.intimp.2022.108899. Epub 2022 Jun 9.
7
Is there a link between neuropathic pain and constipation in NMOSD and MOGAD? Results from an online patient survey and possible clinical implications.视神经脊髓炎谱系疾病(NMOSD)和髓鞘少突胶质细胞糖蛋白抗体相关疾病(MOGAD)中神经病理性疼痛与便秘之间是否存在关联?一项在线患者调查的结果及其可能的临床意义。
Mult Scler Relat Disord. 2022 Jul;63:103825. doi: 10.1016/j.msard.2022.103825. Epub 2022 Apr 26.
8
Aquaporin-4 in Neuromyelitis Optica Spectrum Disorders: A Target of Autoimmunity in the Central Nervous System.视神经脊髓炎谱系疾病中的水通道蛋白-4:中枢神经系统自身免疫的靶点。
Biomolecules. 2022 Apr 17;12(4):591. doi: 10.3390/biom12040591.
9
Progress in treatment of neuromyelitis optica spectrum disorders (NMOSD): Novel insights into therapeutic possibilities in NMOSD.视神经脊髓炎谱系疾病(NMOSD)治疗进展:NMOSD 治疗可能性的新见解。
CNS Neurosci Ther. 2022 Jul;28(7):981-991. doi: 10.1111/cns.13836. Epub 2022 Apr 15.
10
Long Noncoding RNA TUG1 Inhibits Tumor Progression through Regulating Siglec-15-Related Anti-Immune Activity in Hepatocellular Carcinoma.长链非编码 RNA TUG1 通过调节 Siglec-15 相关的抗免疫活性抑制肝癌的肿瘤进展。
J Immunol Res. 2022 Feb 21;2022:9557859. doi: 10.1155/2022/9557859. eCollection 2022.